Trials / Completed
CompletedNCT03915626
Effect of Heat on Rivastigmine TDS Products
Determination of Serum Rivastigmine Levels After Using Rivastigmine Transdermal Delivery Systems With and Without Standardized Heat Application in Healthy Human Volunteers
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- University of Maryland, Baltimore · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This research study is designed to measure the amount of medicine in blood over time after the patch is placed on the skin with and without external heat application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rivastigmine (RLD) transdermal patch | brand name patch |
| DRUG | Rivastigmine (generic) transdermal patch | generic patch |
Timeline
- Start date
- 2019-10-04
- Primary completion
- 2021-05-04
- Completion
- 2021-05-04
- First posted
- 2019-04-16
- Last updated
- 2022-04-04
- Results posted
- 2022-03-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03915626. Inclusion in this directory is not an endorsement.